Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites
Ann M Guggisberg1, Jooyoung Park2, Rachel L Edwards1
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Abstract:
Isoprenoid biosynthesis through the methylerythritol phosphate (MEP) pathway generates commercially important products and is a target for antimicrobial drug development. MEP pathway regulation is poorly understood in microorganisms. Here we employ a forward genetics approach to understand MEP pathway regulation in the malaria parasite, Plasmodium falciparum. The antimalarial fosmidomycin inhibits the MEP pathway enzyme deoxyxylulose 5-phosphate reductoisomerase (DXR). Fosmidomycin-resistant P. falciparum are enriched for changes in the PF3D7_1033400 locus (hereafter referred to as PfHAD1), encoding a homologue of haloacid dehalogenase (HAD)-like sugar phosphatases. We describe the structural basis for loss-of-function PfHAD1 alleles and find that PfHAD1 dephosphorylates a variety of sugar phosphates, including glycolytic intermediates. Loss of PfHAD1 is required for fosmidomycin resistance. Parasites lacking PfHAD1 have increased MEP pathway metabolites, particularly the DXR substrate, deoxyxylulose 5-phosphate. PfHAD1 therefore controls substrate availability to the MEP pathway. Because PfHAD1 has homologues in plants and bacteria, other HAD proteins may be MEP pathway regulators.
Insights
We discovered that the PfHAD1 enzyme regulates the methylerythritol phosphate (MEP) pathway in malaria parasites. Loss of PfHAD1 function increases MEP pathway metabolites, impacting drug resistance.
Area of Science:
- Biochemistry
- Parasitology
- Drug Discovery
Background:
- The methylerythritol phosphate (MEP) pathway is crucial for producing essential compounds and is a target for antimicrobial drug development.
- Understanding MEP pathway regulation in microorganisms, particularly in the malaria parasite Plasmodium falciparum, is critical but remains incomplete.
- The antimalarial drug fosmidomycin targets deoxyxylulose 5-phosphate reductoisomerase (DXR), an enzyme within the MEP pathway.
Purpose of the Study:
- To investigate the regulatory mechanisms of the MEP pathway in Plasmodium falciparum using a forward genetics approach.
- To identify genetic factors contributing to resistance against the MEP pathway inhibitor fosmidomycin.
- To elucidate the function and structural basis of the identified resistance-conferring protein.
Main Methods:
- Forward genetics screen to identify fosmidomycin-resistant Plasmodium falciparum mutants.
- Genetic analysis of mutations in the PF3D7_1033400 locus, encoding PfHAD1.
- Biochemical characterization of PfHAD1 enzyme activity, including substrate specificity and structural analysis.
- Metabolomic analysis of MEP pathway intermediates in wild-type and PfHAD1-deficient parasites.
Main Results:
- Fosmidomycin-resistant P. falciparum exhibited mutations in the PF3D7_1033400 locus, encoding the haloacid dehalogenase (HAD)-like protein PfHAD1.
- Loss-of-function PfHAD1 alleles were necessary for fosmidomycin resistance.
- PfHAD1 dephosphorylates various sugar phosphates, including glycolytic intermediates.
- Parasites lacking PfHAD1 showed elevated levels of MEP pathway metabolites, specifically the DXR substrate deoxyxylulose 5-phosphate.
- Structural analysis provided insights into the loss-of-function mutations.
Conclusions:
- PfHAD1 acts as a negative regulator of the MEP pathway by controlling substrate availability.
- The dephosphorylation activity of PfHAD1 influences the flux through the MEP pathway.
- PfHAD1 is a key factor in regulating fosmidomycin sensitivity in Plasmodium falciparum.
- The discovery of PfHAD1's role suggests that other HAD family proteins may also regulate the MEP pathway in diverse organisms.
More Related Videos
10:22Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
Related Concept Videos
Other Glycolytic Pathways
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Biosynthesis of Nucleic Acids
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Glycolysis: Preparatory Phase